PSTV – plus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal Metastases
Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript [Seeking Alpha]
Plus Therapeutics, Inc. (NASDAQ: PSTV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ... [Yahoo! Finance]
Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Form 424B3 PLUS THERAPEUTICS, INC.
Form 8-K PLUS THERAPEUTICS, INC. For: Nov 14
Form 10-Q PLUS THERAPEUTICS, INC. For: Sep 30
Form 424B3 PLUS THERAPEUTICS, INC.
Form 8-K PLUS THERAPEUTICS, INC. For: Oct 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.